82Y Stock Overview
Provides orthopedic surgical products for use in joint implant surgery in Sweden.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Ortoma AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.74 |
| 52 Week High | SEK 1.42 |
| 52 Week Low | SEK 0.54 |
| Beta | 0.74 |
| 11 Month Change | 4.80% |
| 3 Month Change | 3.34% |
| 1 Year Change | -37.38% |
| 33 Year Change | -79.16% |
| 5 Year Change | n/a |
| Change since IPO | -71.46% |
Recent News & Updates
Recent updates
Shareholder Returns
| 82Y | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -1.3% | -3.7% | -1.9% |
| 1Y | -37.4% | 6.6% | 12.3% |
Return vs Industry: 82Y underperformed the German Medical Equipment industry which returned 6.6% over the past year.
Return vs Market: 82Y underperformed the German Market which returned 12.3% over the past year.
Price Volatility
| 82Y volatility | |
|---|---|
| 82Y Average Weekly Movement | 10.0% |
| Medical Equipment Industry Average Movement | 5.4% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.7% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 82Y's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 82Y's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 7 | Linus Byström | www.ortoma.com |
Ortoma AB (publ) provides orthopedic surgical products for use in joint implant surgery in Sweden. It offers Ortoma Treatment Solution (OTS) that is designed to support various orthopedic joint or spine surgeries in the areas of hip, spine, knee, and shoulders and extremities surgeries; OTS Plan, a software that processes and assists surgeons during pre-operative planning and post-operative follow-up; OTS Guide, an intra-operative navigation tool guiding surgeons to place the implant in the pre-operatively planned position; and OTS Follow up that is used as support in the postoperative follow-up of a patient through a low-dose computed tomography of the joint. The company was incorporated in 2001 and is based in Gothenburg, Sweden.
Ortoma AB (publ) Fundamentals Summary
| 82Y fundamental statistics | |
|---|---|
| Market cap | €29.20m |
| Earnings (TTM) | -€2.70m |
| Revenue (TTM) | €5.44m |
5.4x
P/S Ratio-10.8x
P/E RatioIs 82Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 82Y income statement (TTM) | |
|---|---|
| Revenue | SEK 61.96m |
| Cost of Revenue | SEK 42.23m |
| Gross Profit | SEK 19.73m |
| Other Expenses | SEK 50.51m |
| Earnings | -SEK 30.78m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.83 |
| Gross Margin | 31.84% |
| Net Profit Margin | -49.67% |
| Debt/Equity Ratio | 0% |
How did 82Y perform over the long term?
See historical performance and comparison